icon-folder.gif   Conference Reports for NATAP  
 
  18th International Workshop on
Clinical Pharmacology of Antiviral Therapy
June 14-17, 2017
Chicago, Ill.C
Back grey_arrow_rt.gif
 
 
 
Population Pharmacokinetic Analysis of Voxilaprevir, a Pangenotypic
HCV NS3/4A Protease Inhibitor in Hepatitis C Virus-Infected Subjects

 
 
  Reported by Jules Levin
 
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-16, 2017, Chicago, IL
 
Brian J. Kirby,1 Erik Mogalian,1 Yuying Gao,2 Anita Mathias1
1Gilead Sciences, Inc., Foster City, California, USA; 2Certara Strategic Consulting, Menlo Park, California

0622171

0622172

0622173

0622174

0622175

0622176

0622177

0622178

0622179